These findings are consistent with the notion that the acquisition of metastasis by breast cancer cells coincides with their elevated expression of FAK, which enhances p38 MAPK activation by TGF-β and its pro-metastatic activities. The gene discussed is PTK2; the disease is breast carcinoma.